John Lee
2021 - Decibel Therapeutics
In 2021, John Lee earned a total compensation of $816K as Executive Vice President, Chief Development Officer at Decibel Therapeutics.
Compensation breakdown
Bonus | $200,000 |
---|---|
Non-Equity Incentive Plan | $172,240 |
Salary | $430,677 |
Other | $13,188 |
Total | $816,035 |
Lee received $430.7K in salary, accounting for 53% of the total pay in 2021.
Lee also received $200K in bonus, $172.2K in non-equity incentive plan and $13.2K in other compensation.
Rankings
In 2021, John Lee's compensation ranked 9,430th out of 12,415 executives tracked by ExecPay. In other words, Lee earned more than 24.0% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 9,430 | 24th |
Manufacturing | 4,181 | 24th |
Chemicals And Allied Products | 1,850 | 22nd |
Drugs | 1,642 | 22nd |
Pharmaceutical Preparations | 1,221 | 21st |
Lee's colleagues
We found three more compensation records of executives who worked with John Lee at Decibel Therapeutics in 2021.
News
Marathon Patent Group CFO Hugh Gallagher receives $4.8M in 2022
June 23, 2023
Decibel Therapeutics CEO Laurence Reid's 2022 pay jumps 54% to $1.2M
April 28, 2023
PhaseBio Pharmaceuticals CEO Jonathan Mow's 2021 pay slips 13% to $1.5M
April 22, 2022
PhaseBio Pharmaceuticals CEO Jonathan Mow's 2019 pay jumps 102% to $1.2M
April 24, 2020
PhaseBio Pharmaceuticals CEO Jonathan Mow's 2018 pay jumps 37% to $596K
April 5, 2019